Literature DB >> 872520

Effects of clonidine on biochemical indices of sympathetic function and plasma renin activity in normotensive man.

L M Wing, J L Reid, C A Hamilton, P Sever, D S Davies, C T Dollery.   

Abstract

1. A single oral dose of clonidine hydrochloride (300 microgram) lowered systolic blood pressure by 20+/-2 mmHg and diastolic blood pressure by 15+/-2 mmHg in seven healthy normotensive subjects. 2. Resting supine plasma noradrenaline concentration fell from 2-42+/-0-47 nmol/l before dosing to a minimum of 0-59+/-0-18 nmol/l at 6 h. The value subsequently rose and was not significantly different from that before the dose at 12 h. There was a significant reduction in urinary free catecholamine excretion in the first 12 h after dosing. 3. Resting supine plasma renin activity before dosing was 0-95+/-0-16 pmol of angiotensin I h-1 ml-1 of plasma and rose significantly after clonidine to 3-50+/-0-39 pmol of angiotensin I h-1 ml-1 of plasma at 6 h. By 12 h plasma renin activity had returned to control values. 4. When the same subjects were studied on a control, drug-free, day under the same conditions, there was no significant change in blood pressure or plasma noradrenaline. Although plasma renin activity rose during this control day, it was significantly lower than after clonidine. 5. In normotensive subjects single doses of clonidine lower blood pressure and are associated with a reduction of sympathetic nervous activity. Delayed elevation of plasma renin activity may be secondary to the fall in blood pressure. There is no evidence for an overshoot of sympathetic activity after a single dose of clonidine.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 872520     DOI: 10.1042/cs0530045

Source DB:  PubMed          Journal:  Clin Sci Mol Med        ISSN: 0301-0538


  20 in total

1.  A comparison of the haemodynamic and behavioural effects of moxonidine and clonidine in normotensive subjects.

Authors:  G J Macphee; C A Howie; H L Elliott; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1992-03       Impact factor: 4.335

2.  Effect of labetalol on plasma noradrenaline and adrenaline in hypertensive man.

Authors:  N J Christensen; J Trap-Jensen; T L Svendsen; S Rasmussen; P E Nielsen
Journal:  Eur J Clin Pharmacol       Date:  1978-12-01       Impact factor: 2.953

3.  How intrinsic sympathomimetic activity modulates the haemodynamic responses to beta-adrenoceptor antagonists. A clue to the nature of their antihypertensive mechanism.

Authors:  A J Man in 't Veld; M A Schalekamp
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

4.  Plasma noradrenaline concentration in essential hypertension during long-term beta-adrenoceptor blockade with oxprenolol.

Authors:  D H Jones; J Daniel; C A Hamilton; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1980-01       Impact factor: 4.335

5.  Effect of indoramin, labetalol and alinidine on sympathetic function in normal man.

Authors:  D P Nicholls; J McNeill; P C O'Connor; D W Harron; W J Leahey; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1984-08       Impact factor: 4.335

6.  Effects of azepexole and clonidine on baroreceptor mediated reflex bradycardia and physiological tremor in man.

Authors:  D W Harron; J G Riddell; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1985-11       Impact factor: 4.335

7.  Clonidine as a sedative adjunct in intensive care.

Authors:  H Böhrer; A Bach; M Layer; P Werning
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

8.  The effects of desmethylimipramine on the pharmacological actions of alpha methyldopa in man.

Authors:  J L Reid; A J Porsius; C Zamboulis; G Polak; C A Hamilton; C R Dean
Journal:  Eur J Clin Pharmacol       Date:  1979-09       Impact factor: 2.953

9.  Respiratory, metabolic and hemodynamic effects of clonidine in ventilated patients presenting with withdrawal syndrome.

Authors:  Domniki Liatsi; Basilis Tsapas; Smaro Pampori; Matthew Tsagourias; Ioannis Pneumatikos; Dimitrios Matamis
Journal:  Intensive Care Med       Date:  2008-08-16       Impact factor: 17.440

10.  Antihypertensive effects of lofexidine in patients with essential hypertension.

Authors:  T C Fagan; S S Bloomfield; T D Cowart; R H Corns-Hurwitz; R J Lipicky; E C Conradi; C Y Hsu; W J Grossman; G E Harmon; W J Degenhart; A W Sinkfield; T E Gaffney
Journal:  Br J Clin Pharmacol       Date:  1982-03       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.